Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study

• Príomhchruthaitheoirí: Agathe Turpin (Údar), Laura Semenzato (Údar), Stéphane Le Vu (Údar), Marie-Joëlle Jabagi (Údar), Kim Bouillon (Údar), Jérôme Drouin (Údar), Marion Bertrand (Údar), Lukshe Kanagaratnam (Údar), Alain Weill (Údar), Rosemary Dray-Spira (Údar), Mahmoud Zureik (Údar), Jérémie Botton (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2024-07-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: In spite of major effectiveness, a residual risk after COVID-19 primary vaccination was identified, in particular, for vulnerable individuals of advanced age or with comorbidities. Less is known about the Omicron period in people protected by a booster dose. We aimed to identify the char...